---
schema_version: "secwatch.filing_event.v1"
accession: "0001787306-21-000013"
form_type: "8-K"
ticker: "ARQT"
cik: "0001787306"
company_name: "Arcutis Biotherapeutics, Inc."
filed_at: "2021-09-07T23:59:59+00:00"
generated_at: "2026-06-29T05:35:19.409028+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Arcutis appoints Keith Leonard as Class I director; Ricky Sun resigns without disagreement

## Summary
- Keith R. Leonard Jr. appointed Class I director, term expiring at 2024 annual meeting, effective Sept 2.
- Ricky Sun resigned from Board effective Sept 2; no disagreement with company operations or policies.
- Leonard joins Compensation Committee; receives 32,907-share stock option (3-year annual vest).
- Annual cash retainer of $40,000 for Board service plus $7,500 for Compensation Committee membership.
- Leonard to enter standard indemnification agreement with Arcutis.

## SEC filing metadata
- accession: 0001787306-21-000013
- form_type: 8-K
- ticker: ARQT
- cik: 0001787306
- company_name: Arcutis Biotherapeutics, Inc.
- filed_at: 2021-09-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787306/000178730621000013/0001787306-21-000013-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787306/000178730621000013/arqt-20210903.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001787306-21-000013
- JSON: https://secwatch.observer/filing/0001787306-21-000013.json
- Plain text: https://secwatch.observer/filing/0001787306-21-000013.txt

## Key facts
- Executive change
  Keith R. Leonard Jr. was appointed as Class I director at Arcutis Biotherapeutics, Inc..
  - Action: appointed
  - Role: Class I director
  source text: On September 2, 2021, the Board of Directors (the “Board”) of Arcutis Biotherapeutics, Inc. (the “Company” or “Arcutis”) appointed Keith R. Leonard Jr. as a Class I director with a term expiring at the Company’s 2024 Annual Meeting of Stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787306/000178730621000013/0001787306-21-000013-index.htm
- Executive change
  Ricky Sun resigned as Director at Arcutis Biotherapeutics, Inc..
  - Action: resigned
  - Role: Director
  source text: Mr. Leonard fills the vacancy created by the resignation of Ricky Sun, Ph.D. who resigned from the Board effective September 2, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787306/000178730621000013/0001787306-21-000013-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.